Ireland · Investor

Shire

Last cheque observed Feb 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VCNow at takeda.com

Series BSeries DGrowthAnalyticsMedical DeviceBiopharma

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque3182days00hrs00min00sec
Median round$53MRounds led0 of 10Sole investor1 roundsMostly inUnited States, 90%
Pitch Shire

Shire highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Series B and Series D: 67% of its rounds

  3. 03

    Sole investor in 1 rounds, median $3.0M

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
AnalyticsMedical DeviceBiopharma
Based in
San Diego, Ireland
Cold pitches
Not stated

The record

Every round we can evidence, newest first10 appearances

  1. 2018

    1 round

  2. Feb
    Rani TherapeuticsUS · FinSMEs$53MWith 8 others
  3. 2014

    1 round

  4. Mar
    NeuroPhage PharmaceuticalsSeries D · US$17MWith 1 other
  5. 2013

    2 rounds

  6. May
    NeuroPhage PharmaceuticalsSeries C · US$6.4MWith 1 other
  7. May
    NeuroPhage PharmaceuticalsGrowth · US · finsmes.com$6.4MWith 1 other
  8. 2012

    4 rounds

  9. Nov
    ArmaGen TechnologiesSeries A · US · prnewswire.com$17MWith 3 others
  10. Oct
    PromediorSeries D · US · masshightech.com$3.0MSole investor
  11. Mar
    Promethera BiosciencesSeries B · BE · finsmes.com$31MWith 2 others
  12. Mar
    NeuroPhage PharmaceuticalsSeries B · US · finsmes.com$9.0MWith 2 others
  13. 2011

    2 rounds

  14. May
    Prexa PharmaceuticalsSeries B · US · prexainc.com$7.0MWith 1 other
  15. Mar
    NeuroPhage PharmaceuticalsSeries B · US · neurophage.com$12MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Companies it bought

Acquisitions by the firm itself

Dyax$5.9BNov 2015
Foresight Biotherapeutics$300MAug 2015
Meritage Pharma$245MFeb 2015
NPS Pharmaceuticals$5.2BJan 2015
Lumena Pharmaceuticals$260MMay 2014
Fibrotech Therapeutics$75MMay 2014
ViroPharma$4.2BNov 2013
SARcode Bioscience$160MMar 2013
Advanced BioHealing$750MMay 2011
Movetis$565MAug 2010
Jerini$554MJul 2008

Who they invest alongside

The investors most often in the same rounds as Shire. A count of rooms they were both in, not a relationship either has claimed.

Merieux DeveloppementPrivate equity5rounds togetherBoehringer Ingelheim Venture FundCorporate VC2rounds togetherMitsui Global InvestmentCorporate VC2rounds together

Quick answers about Shire

What does Shire invest in?

Shire invests most often at Series B and Series D (67% of the rounds on record), in sectors such as Analytics, Medical Device and Biopharma.

How active is Shire?

10 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2018.

What has Shire invested in recently?

Its most recent investments on record: Rani Therapeutics (Undisclosed round, Feb 2018).

How big are Shire's cheques?

The median round it joins is $53M.

Does Shire lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does Shire invest?

Most of the companies it backs are in the United States (90%) and Belgium (10%).

Is Shire investing now?

No investments in the last 12 months; the latest was in Feb 2018.

Who does Shire invest alongside?

Most often Merieux Developpement (5 rounds together), Boehringer Ingelheim Venture Fund (2 rounds together) and Mitsui Global Investment (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it